メチルジゴキシン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/01/28 09:59:00」(JST)
[Wiki en表示]
Metildigoxin
|
Systematic (IUPAC) name |
(3β,5β,12β)-3-{[2,6-dideoxy-4-O-methyl-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
|
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy
category |
|
Identifiers |
CAS Number |
30685-43-9 |
ATC code |
C01AA08 |
PubChem |
CID 443946 |
ChemSpider |
392000 Y |
UNII |
I7GG1YUC5V Y |
Synonyms |
4-[(3S,5R,8R,9S,10S,12R,13S,14S)-12,14-Dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one |
Chemical data |
Formula |
C42H66O14 |
Molar mass |
794.965 |
SMILES
-
O=C\1OC/C(=C/1)[C@H]2CC[C@@]8(O)[C@]2(C)[C@H](O)C[C@H]7[C@H]8CC[C@H]6[C@]7(C)CC[C@H](O[C@@H]5O[C@H](C)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@@H]3O[C@@H]([C@@H](OC)[C@@H](O)C3)C)[C@@H](O)C4)C)[C@@H](O)C5)C6
|
InChI
-
InChI=1S/C42H66O14/c1-20-37(49-6)29(43)16-35(51-20)55-39-22(3)53-36(18-31(39)45)56-38-21(2)52-34(17-30(38)44)54-25-9-11-40(4)24(14-25)7-8-27-28(40)15-32(46)41(5)26(10-12-42(27,41)48)23-13-33(47)50-19-23/h13,20-22,24-32,34-39,43-46,48H,7-12,14-19H2,1-6H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m1/s1 Y
-
Key:IYJMSDVSVHDVGT-PEQKVOOWSA-N Y
|
(verify) |
Metildigoxin (INN, or medigoxin BAN, or methyldigoxin) is a cardiac glycoside,[1] a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). The substance is closely related to digoxin; it differs from the latter only by an O-methyl group on the terminal monosaccharide.
References
- ^ Hayward, R.; Greenwood, H.; Stephens, J.; Hamer, J. (1983). "Relationship between myocardial uptake and actions in heart failure of methyldigoxin". British Journal of Clinical Pharmacology 15 (1): 41–48. doi:10.1111/j.1365-2125.1983.tb01461.x. PMC 1427830. PMID 6849743.
Cardiac glycosides (C01A)
|
|
Bufadienolides |
Bufo
|
- Arenobufagin
- Bufotalin
- Cinobufagin
- Marinobufagin
|
|
Scilla
|
- Proscillaridin
- Scilliroside
|
|
|
Cardenolides |
Digitalis
|
- Acetyldigitoxin
- Acetyldigoxin
- Digitoxin#
- Digoxin#
- Lanatoside C
- Deslanoside
- Metildigoxin
- Gitoformate
|
|
Kalanchoe
|
|
|
Strophanthus
|
- Ouabain (g-Strophanthin)
- k-Strophanthin
- Cymarin
|
|
Thevetia
|
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
Index of the heart
|
|
Description |
- Anatomy
- Physiology
- Development
|
|
Disease |
- Injury
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
- Blood tests
|
|
Treatment |
- Procedures
- Drugs
- glycosides
- other stimulants
- antiarrhythmics
- vasodilators
|
|
|
English Journal
- Simultaneous analysis of cardiac glycosides in blood and urine by thermoresponsive LC-MS-MS.
- Kanno S1, Watanabe K, Yamagishi I, Hirano S, Minakata K, Gonmori K, Suzuki O.
- Analytical and bioanalytical chemistry.Anal Bioanal Chem.2011 Jan;399(3):1141-9. doi: 10.1007/s00216-010-4405-1. Epub 2010 Nov 15.
- A new thermoresponsive polymer separation column was applied to simultaneous analysis of four cardiac glycosides (CGs) being widely used for the treatment of arrhythmias and heart failure in human blood and urine. This column is composed of an N-isopropylacrylamide polymer, the surface of which unde
- PMID 21076957
- Free and total digoxin in serum during treatment of acute digoxin poisoning with Fab fragments: case study.
- Eyer F1, Steimer W, Müller C, Zilker T.
- American journal of critical care : an official publication, American Association of Critical-Care Nurses.Am J Crit Care.2010 Jul;19(4):391-87. doi: 10.4037/ajcc2009227. Epub 2009 Oct 29.
- A woman ingested 10 mg of methyldigoxin in a suicide attempt and presented 19 hours after ingestion with clinical signs of glycoside intoxication. Her serum level of digoxin was 7.4 ng/mL, and antidotal therapy with Fab antibody fragments was started. The manufacturer's recommended dosing scheme was
- PMID 19875723
- Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
- Hauck C1, Potter T, Bartz M, Wittwer T, Wahlers T, Mehlhorn U, Scheiner-Bobis G, McDonough AA, Bloch W, Schwinger RH, Müller-Ehmsen J.
- European journal of pharmacology.Eur J Pharmacol.2009 Nov 10;622(1-3):7-14. doi: 10.1016/j.ejphar.2009.08.039. Epub 2009 Sep 12.
- Cardiac glycosides inhibit the Na(+),K(+)-ATPase and are used for the treatment of symptomatic heart failure and atrial fibrillation. In human heart three isoforms of Na(+),K(+)-ATPase are expressed: alpha(1)beta(1), alpha(2)beta(1) and alpha(3)beta(1). It is unknown, if clinically used cardiac glyc
- PMID 19751721
Japanese Journal
- 三尖弁閉鎖不全症犬において右心内圧と血中ANPならびにNT-proBNP濃度を測定した1例
- 循環器病棟における薬学的支援の取り組み(誌上シンポジウム)
Related Links
- The efficacy on congestive heart failure of metildigoxin (β-methyldigoxin, MD), a derivative of digoxin (DX), which had a good absorption rate from digestive tract, was examined in a double blind study using a group comparison method.
- We conducted the present study to obtain basic information about monitoring f-SGC in patients receiving beta-methyldigoxin (BMD), using TDx digoxin assay.<BR>The results showed that accuracy of the f-SGC detected with TDx ...
Related Pictures
★リンクテーブル★
[★]
- 英
- metildigoxin, methyldigoxin
- 商
- ラニラピッド
- 関
- ジゴキシン、ジギタリス
- 強心配糖体
- ジゴキシンより吸収率が高く、速やかに効果を現す